Abstract
Aims and Background: T helper (Th)1/Th2 immune response has been linked to obesity-related immune disorders. It has been proven that retinoid active derivates improve immunity via regulating Th1/Th2 balance. However, there is not a well-identified report of direct effect of vitamin A on Th1/Th2 balance in obesity. The present study aimed to investigate the possible role of vitamin A on serum Th1/Th2 response in obese women. Materials and Methods: A randomized double-blind placebo-controlled trial was conducted on 84 obese (n = 56; body mass index [BMI] 30–39.9 kg/m2) and nonobese (n = 28; BMI 18.5–24.9 kg/m2) women. Obese women were randomly allocated to receive either vitamin A (retinyl palmitate 25,000 IU/d) or placebo. Nonobese women also received 25,000 IU/d retinyl palmitate. Anthropometric variables were assessed and serum interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-4, and IL-13 were analyzed before and 4 months after intervention. Results: Vitamin A treatment significantly reduced serum concentrations of IL-1β in obese vitamin A–treated subjects (from 3.58 ± 0.36 to 2.45 ± 0.23 pg/ml, p < 0.006). Serum concentrations of IL-4 and IL-13 were also reduced in obese and nonobese vitamin A–treated subjects (p < 0.05). A significant reduction in IL-1β/IL-4 ratio in the obese vitamin A–treated group was also observed (p = 0.03). Conclusions: Decline in serum concentrations of IL-1β and IL-1β/IL-4 ratio in obese women suggests that vitamin A is capable of regulating the immune system and possibly reducing the risk of autoimmune disease in this group. Further studies are needed to explore the possible underlying mechanisms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have